Jana Šímová - Concepedia

Author

Jana Šímová

Czech Academy of Sciences, Institute of Molecular Genetics

Also Known As

J SIMOVA, J Simova, J Simová, J Símova, J Símová, J Šímová, J. Simova, J. Simová, J. Símová, J. Šimová

412

Publications

1.2K

Citations

H-Index

Concepts

All Affiliations

Czech Academy of Sciences, Institute of Molecular Genetics Czech Academy of Sciences Charles University Danish Cancer Society Wenner-Gren Foundations

JŠ

About

Jana Šímová is an author at Czech Academy of Sciences, Institute of Molecular Genetics specializing in tumor microenvironment, medicine, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	19	625
2	Immunology	12	17	542
3	Cell Biology	7	7	297
4	Health Sciences	4	4	162
5	Cellular Therapies	1	1	12

Jana Šímová

Publications

874

Citations

H-Index

Page 1

	Year	Citations
Immunotheraphy of cancer using local administration of lymphoid cells transformed by IL-2 cDNA and constitutively producing IL-2 J Bubeník, Jana Šímová, T Jandlová Immunology Letters Local AdministrationLymphoid NeoplasiaCancer ImmunosurveillanceIl-2 CdnaImmunology	1990	85
Induction of MHC class I molecule cell surface expression and epigenetic activation of antigen‐processing machinery components in a murine model for human papilloma virus 16‐associated tumours Jasper Manning, M Indrová, Barbora Lubyová, Immunology	2007	85
Local administration of cells containing an inserted IL-2 gene and producing IL-2 inhibits growth of human tumours in nu/nu mice J Bubeník, Nikolai N. Voitenok, J. Kieler, Immunology Letters Local AdministrationTumor BiologyCytokineImmunologyCell Proliferation	1988	80
Radiotherapy-induced plasticity of prostate cancer mobilizes stem-like non-adherent, Erk signaling-dependent cells Lenka Kyjacová, Soňa Hubáčková, Kateřina Krejčíková, Cell Death and Differentiation Radiotherapy-induced PlasticityLineage PlasticityMedicineProstatic DiseaseStem Cell Trafficking	2014	70
Growth inhibition of a MC-induced mouse sarcoma by TCGF (IL 2)-containing preparations J Bubeník, Peter Perlmann, M Indrová, Cancer Immunology Immunotherapy Mc-induced Mouse SarcomaIl 2ImmunologyGrowth InhibitionCell Proliferation	1983	62
Cyclophosphamide-induced Myeloid-derived Suppressor Cell Population Is Immunosuppressive But Not Identical to Myeloid-derived Suppressor Cells Induced By Growing TC-1 Tumors Romana Mikyšková, M Indrová, Veronika Polláková, Journal of Immunotherapy Mdsc AccumulateImmunologyImmune RegulationPathologyImmunoediting	2012	53
DNA demethylating agent 5-azacytidine inhibits myeloid-derived suppressor cells induced by tumor growth and cyclophosphamide treatment Romana Mikyšková, M Indrová, Veronika Vlková, Journal of Leukocyte Biology	2014	51
Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status Jana Šímová, Veronika Polláková, M Indrová, British Journal of Cancer	2011	44
Treatment of minimal residual disease after surgery or chemotherapy in mice carrying HPV16-associated tumours: Cytokine and gene therapy with IL-2 and GM-CSF Romana Mikyšková, M Indrová, Jana Šímová, International Journal of Oncology Hpv16-associated TumoursIl-2 Gene TherapyImmunologyImmune RegulationPathology	2004	42
Epigenetic regulations in the IFNγ signalling pathway: IFNγ-mediated MHC class I upregulation on tumour cells is associated with DNA demethylation of antigen-presenting machinery genes Veronika Vlková, Ivan Štěpánek, Veronika Hrušková, Oncotarget	2014	40

Page 1